切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2023, Vol. 12 ›› Issue (03) : 356 -359. doi: 10.3877/cma.j.issn.2095-3232.2023.03.022

所属专题: 综述

综述

多房棘球蚴病患者营养评估及干预措施
朱青1, 马洁1, 戴尧1, 庞明泉1, 樊海宁1, 崔红元2,()   
  1. 1. 810000 西宁,青海大学附属医院肝胆胰外科
    2. 810000 西宁,青海大学附属医院肝胆胰外科;100730 北京医院肝胆外科
  • 收稿日期:2023-02-20 出版日期:2023-06-10
  • 通信作者: 崔红元
  • 基金资助:
    青海省科技成果转化专项项目(2020-SF-162)

Nutrition assessment and treatments for patients with Alveolar echinococcosis

Qing Zhu1, Jie Ma1, Yao Dai1   

  • Received:2023-02-20 Published:2023-06-10
引用本文:

朱青, 马洁, 戴尧, 庞明泉, 樊海宁, 崔红元. 多房棘球蚴病患者营养评估及干预措施[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 356-359.

Qing Zhu, Jie Ma, Yao Dai. Nutrition assessment and treatments for patients with Alveolar echinococcosis[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 356-359.

棘球蚴病是一种严重且广泛流行的人畜共患寄生虫病,主要由棘球蚴幼虫寄生在人体肝脏所致。目前感染人体的棘球蚴病主要分两型,即多房棘球蚴病(Alveolar echinococcosis,AE)和细粒棘球蚴病(Cystic echinococcosis,CE)。其中,AE比较特殊,作为好发于肝的慢性消耗性疾病,病变对肝脏和周围组织、器官的持续损伤压迫,影响消化,使患者出现营养不良的症状,如白蛋白减少和消瘦,可给患者造成严重的身体伤害和经济损失[1]。而营养不良会损害身体对手术和感染等压力事件的免疫抵抗力,还会损害身体器官和组织的功能,并影响患者的临床结局,比如增加手术后并发症发生率和死亡率,延长住院时间,增加医疗总费用等[2]。既往有研究显示,入院AE患者营养不良发生率高达17.8%~18%[3,4]。因此,深入了解AE患者营养不良发生的原因和机制,通过早期营养风险筛查和评估,及积极的干预措施可改善AE患者的临床结局和预后。

[1]
马豹, 邓勇, 王志鑫, 等. 泡型肝包虫病患者营养不良发生机制的初步探讨[J]. 临床肝胆病杂志, 2018, 34(1):204-206.
[2]
Liang X, Shu W, Linyong Z, et al. Preoperative nutritional evaluation of patients with hepatic alveolar echinococcosis[J]. PLoS One, 2020, 15(2):e0229396.
[3]
王灏. 141例肝泡型包虫病住院病例临床特征分析[D]. 西宁: 青海大学, 2013.
[4]
胡娇, 罗艳丽, 肖凤鸣, 等. 泡型肝包虫病患者营养不良的危险因素分析[J]. 解放军预防医学杂志, 2019, 37(4):9-10.
[5]
汪天平, 操治国. 中国棘球蚴病防控进展及其存在的问题[J].中国寄生虫学与寄生虫病杂志, 2018, 36(3):291-296.
[6]
Saengnipanthkul S, Chongviriyaphan N, Densupsoontorn N, et al. Hospital-acquired malnutrition in paediatric patients: a multicentre trial focusing on prevalence, risk factors, and impact on clinical outcomes[J]. Eur J Pediatr, 2021, 180(6):1761-1767.
[7]
Pereira MG, Carvalho C, Costa ECV, et al. Quality of life in chronic pain patients: illness- and wellness-focused coping as moderators[J]. Psych J, 2021, 10(2):283-294.
[8]
Zhang C, Wang J, G, et al. Hepatocyte proliferation/growth arrest balance in the liver of mice during E. multilocularis infection:a coordinated 3-stage course[J]. PLoS One, 2012, 7(1):e30127.
[9]
Anker MS, Landmesser U, von Haehling S, et al. Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers[J].J Cachexia Sarcopenia Muscle, 2021, 12(1):9-13.
[10]
中华医学会肝病学分会, 中华医学会消化病学分会. 终末期肝病临床营养指南[J]. 临床肝胆病杂志, 2019, 35(6):1222-1230.
[11]
Tandon P, Low G, Mourtzakis M, et al. A model to identify sarcopenia in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2016, 14(10):1473-1480, e3.
[12]
Tandon P, Raman M, Mourtzakis M, et al. A practical approach to nutritional screening and assessment in cirrhosis[J]. Hepatology, 2017, 65(3):1044-1057.
[13]
石汉平, 丛明华, 陈伟. 再论营养不良的三级诊断[J/CD]. 中国医学前沿杂志(电子版), 2020, 12(1):前插1, 1-7.
[14]
马豹. 不同营养评价方法对肝泡型包虫病患者的适用性研究[D]. 西宁: 青海大学, 2018.
[15]
Jensen GL, Cederholm T, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community[J]. JPEN J Parenter Enteral Nutr, 2019, 43(1): 32-40.
[16]
Allard JP, Keller H, Gramlich L, et al. GLIM criteria has fair sensitivity and specificity for diagnosing malnutrition when using SGA as comparator[J]. Clin Nutr, 2020, 39(9):2771-2777.
[17]
Skeie E, Tangvik RJ, Nymo LS, et al. Weight loss and BMI criteria in GLIM's definition of malnutrition is associated with postoperative complications following abdominal resections-results from a National Quality Registry[J]. Clin Nutr, 2020, 39(5):1593-1599.
[18]
Schuetz P, Seres D, Lobo DN, et al. Management of disease-related malnutrition for patients being treated in hospital[J]. Lancet, 2021, 398(10314):1927-1938.
[19]
Nigatu YD, Gebreyesus SH, Allard JP, et al. The effect of malnutrition at admission on length of hospital stay among adult patients in developing country: a prospective cohort study[J]. Clin Nutr ESPEN, 2021(41):217-224.
[20]
Efthymiou A, Hersberger L, Reber E, et al. Nutritional risk is a predictor for long-term mortality: 5-year follow-up of the EFFORT trial[J]. Clin Nutr, 2021, 40(4):1546-1554.
[21]
Gomes F, Baumgartner A, Bounoure L, et al. Association of nutritional support with clinical outcomes among medical inpatients who are malnourished or at nutritional risk: an updated systematic review and meta-analysis[J]. JAMA Netw Open, 2019, 2(11): e1915138.
[22]
Correia MITD, Perman MI, Waitzberg DL. Hospital malnutrition in Latin America: a systematic review[J]. Clin Nutr, 2017, 36(4):958-967.
[23]
Ren B, Chen X, Lei P, et al. The relationship between preoperative systemic immune inflammation index and prognostic nutritional index and the prognosis of patients with alveolar hydatid disease[J]. Front Immunol, 2021(12):691364.
[24]
陈小彬, 袁加琪, 许召君, 等. 预后营养指数对肝泡型包虫病患者预后的预测价值[J]. 临床肝胆病杂志, 2021, 37(5):1147-1151.
[25]
崔红元, 朱明炜, 陈伟, 等. 中国老年住院患者营养状态的多中心调查研究[J]. 中华老年医学杂志, 2021, 40(3):364-369.
[26]
中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8):711-721.
[27]
Lobo DN, Gianotti L, Adiamah A, et al. Perioperative nutrition: recommendations from the ESPEN expert group[J]. Clin Nutr, 2020, 39(11):3211-3227.
[28]
Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr, 2019, 38(2):485-521.
[29]
刘婧, 乔馨瑶, 石磊, 等. 2017~2019年肝病营养指南的质量评价及对比解读[J]. 中国循证医学杂志, 2020, 20(9):1083-1091.
[30]
Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis[J].J Gastroenterol Hepatol, 2012, 27(3):430-441.
[31]
Puri P, Dhiman RK, Taneja S, et al. Nutrition in chronic liver disease: consensus statement of the Indian National Association for study of the liver[J]. J Clin Exp Hepatol, 2021, 11(1):97-143.
[32]
Koop AH, Mousa OY, Pham LE, et al. An argument for vitamin D, A, and zinc monitoring in cirrhosis[J]. Ann Hepatol, 2018, 17(6):920-932.
[33]
Chen T, Zuo X, Wang S, et al. The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: a protocol for a systematic review and meta-analysis[J]. Medicine, 2020, 99(19):e20296.
[34]
Moszak M, Szulińska M, Walczak-Gałęzewska M, et al. Nutritional approach targeting gut microbiota in NAFLD-to date[J]. Int J Environ Res Public Health, 2021, 18(4):1616.
[35]
Cao Q, Yu CB, Yang SG, et al. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: a meta-analysis[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(1):9-16.
[36]
Bischoff SC, Bernal W, Dasarathy S, et al. ESPEN practical guideline: clinical nutrition in liver disease[J]. Nutr Hosp, 2022, 39(2):434-472.
[37]
Reintam Blaser A, Starkopf J, Alhazzani W, et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines[J]. Intensive Care Med, 2017, 43(3):380-398.
[38]
Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: clinical nutrition in cancer[J]. Clin Nutr, 2021, 40(5): 2898-2913.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 严华悦, 刘子祥, 周少波. 磷酸烯醇式丙酮酸羧激酶-1在恶性肿瘤中的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 452-456.
[3] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[6] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[7] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[8] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[9] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[10] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[11] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[12] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[13] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[14] 张平骥, 徐钰, 李天水, 庞文翼, 符师宁, 张梦圆. 重症患者镇静治疗现状及期望的调查研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 562-567.
[15] 王昌前, 林婷婷, 宁雨露, 王颖杰, 谭文勇. 光免疫治疗在肿瘤领域的临床应用新进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 575-583.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?